HU215435B - Method for producing substitute for dermal tissue, and biological carrier suitable for cultivating cell cultures - Google Patents
Method for producing substitute for dermal tissue, and biological carrier suitable for cultivating cell culturesInfo
- Publication number
- HU215435B HU215435B HU3522/90A HU352290A HU215435B HU 215435 B HU215435 B HU 215435B HU 3522/90 A HU3522/90 A HU 3522/90A HU 352290 A HU352290 A HU 352290A HU 215435 B HU215435 B HU 215435B
- Authority
- HU
- Hungary
- Prior art keywords
- cell cultures
- carrier suitable
- dermal tissue
- biological carrier
- cultivating cell
- Prior art date
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A találmány tárgya eljárás sejttenyészeteknél alkalmazható biőlógiaihőrdőzó előállítására, amelyre jellemző, hőgy grammőnként legalább 0,9g fibrinőgént, 0,03–0,1 g fibrőnektint és legalább 0,1 NE XIII-asfaktőrt tartalmazó plazmafehérje-kőncentrátűmból 100–120 g/mlvégkőncentrációjú vizes szűszpenziót készítünk 1000–10 000 KIU/mlkőncentrációjú aprőtinint tartalmazó vizes őld tban, majd a kapőttszűszpenziót azőnős térfőgatú trőmbin-kalciűmmal keverjük össze, majda keverékhez kívánt esetben sejtősztódást segítő anyagőt és/vagyantibiőtikűmőt és/vagy sebgyógyűlást segítő nyagőt adűnk. ŕField of the Invention The present invention relates to a method for producing a bioprotectant for cell cultures, characterized in that it has an aqueous suspension of 100-120 g / ml of final concentration of plasma protein concentrate containing at least 0.9 g of fibrin gene per gram, 0.03-0.1 g of fibrinectin and at least 0.1 IU of XIII asphalt. prepared in an aqueous beer containing 1000 to 10,000 KIU / pound of quinine, then mix the pellet slurry with primordial spheroidal trinium calcine, if desired, additive material and / or antipyretic and / or wound healing aid is added to the mixture. ŕ
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU3522/90A HU215435B (en) | 1990-06-07 | 1990-06-07 | Method for producing substitute for dermal tissue, and biological carrier suitable for cultivating cell cultures |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU3522/90A HU215435B (en) | 1990-06-07 | 1990-06-07 | Method for producing substitute for dermal tissue, and biological carrier suitable for cultivating cell cultures |
Publications (3)
Publication Number | Publication Date |
---|---|
HU903522D0 HU903522D0 (en) | 1990-10-28 |
HUT58790A HUT58790A (en) | 1992-03-30 |
HU215435B true HU215435B (en) | 1999-04-28 |
Family
ID=10964382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU3522/90A HU215435B (en) | 1990-06-07 | 1990-06-07 | Method for producing substitute for dermal tissue, and biological carrier suitable for cultivating cell cultures |
Country Status (1)
Country | Link |
---|---|
HU (1) | HU215435B (en) |
-
1990
- 1990-06-07 HU HU3522/90A patent/HU215435B/en unknown
Also Published As
Publication number | Publication date |
---|---|
HUT58790A (en) | 1992-03-30 |
HU903522D0 (en) | 1990-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69535328D1 (en) | IN-VITRO GROWTH OF LANGERHANS'SCHEN ISLANDS AND ITS USES | |
NO993709D0 (en) | Stabilized composition comprising fibrinogen | |
EP0259475A4 (en) | Recombinant human endothelial cell growth factor. | |
NO901852L (en) | PROCEDURE FOR PREPARING LIPOSOMES. | |
DE69034018D1 (en) | COMBINED USE OF HYALURONIC ACID AND THERAPEUTIC ACTIVE SUBSTANCES TO IMPROVE THE THERAPEUTIC EFFECT | |
KR870005647A (en) | Stabilized Human Tissue Plasminogen Activator Composition | |
DK85786A (en) | BIOLOGICALLY ACTIVE FRAGMENTS OF HUMAN ANTIHAEMOPHILIC FACTOR AND METHOD OF PRODUCING THEREOF | |
ATE96167T1 (en) | PROCESS FOR CRYSTALLIZATION OF ENZYMES. | |
ES8800601A1 (en) | Solid hydrochloride salt of t-PA | |
EP0216742A3 (en) | Growth factors | |
EP0233013A3 (en) | Modified enzyme | |
KR890003952A (en) | New Tissue Plasminogen Activator | |
GR3007248T3 (en) | ||
FI20075338A (en) | No looping changes to gb350 / 220 | |
FR2563108B1 (en) | ANTIACID PHARMACEUTICAL COMPOSITION AND AQUEOUS SUSPENSION CONTAINING THE SAME | |
ES2013500A6 (en) | Variants of plasminogen activators and processes for their production. | |
FR2506616A1 (en) | PREPARATION OF GAMMA-GLOBULIN FOR INTRAVENOUS INJECTION AND MANUFACTURING PROCESS, AND THERAPEUTIC AGENT THUS PRODUCED | |
Nakagawa et al. | Tumor necrosis factor stimulates gelatinase and collagenase production by granulation tissue in culture | |
AU7379687A (en) | A process for obtaining active proteins from a biologically inactive form | |
HU215435B (en) | Method for producing substitute for dermal tissue, and biological carrier suitable for cultivating cell cultures | |
GR860329B (en) | Reagent for the dosage of antibodies against bacteric toxines by hemaglutination method for preparation and application thereof | |
FR2594845B1 (en) | MICROBIOLOGICAL PREPARATION OF THE HUMAN PLASMINOGEN TISSUE ACTIVATOR (T-PA) AND CONVERSION OF THE ENZYME SO OBTAINED IN ITS ACTIVE FORM | |
ATE191923T1 (en) | INTERLEUKINE-6 MUTANT WITH IMPROVED BIOLOGICAL ACTIVITY COMPARED TO WILD-TYPE IL-6 | |
ATE127520T1 (en) | PROTEIN WITH TRANSACTIVATION PROPERTY, VECTORS EXPRESSING THIS PROTEIN, CELL LINES AND ITS USES. | |
ES8702463A1 (en) | Absorbent polymer material and its preparation. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB9A | Succession in title |
Owner name: ETABLISSEMENT FRANçAIS DU SANG, FR Free format text: FORMER OWNER(S): CENTRE REGIONAL DE TRANSFUSION SANGUINE DE LILLE, FR |